
Browsing restrictions can be lifted for a fee.
-2.48%
Pmgc holdings inc.
0.05%
Avg of Sector
-0.31%
S&P500

Browsing restrictions can be lifted for a fee.
| Quarterly | EPS Forecast | QoQ | Max | Min |
|---|---|---|---|---|
| 2026Q1 | ||||
| 2026Q2 | ||||
| 2026Q3 | ||||
| 2026Q4 | ||||
| 2027Q1 |
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2025Q4 | |||||||
| 2025Q3 | |||||||
| 2025Q2 | |||||||
| 2025Q1 |
The most recent financial report for Pmgc holdings inc. (ELAB) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating ELAB's short-term business performance and financial health. For the latest updates on ELAB's earnings releases, visit this page regularly.
According to the latest financial report, Pmgc holdings inc. (ELAB) reported an Operating Profit of -2.2M with an Operating Margin of -768.99% this period, representing a decline of 139.28% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, Pmgc holdings inc. (ELAB) announced revenue of 285.95K, with a Year-Over-Year growth rate of -45.79%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
As of the end of the reporting period, Pmgc holdings inc. (ELAB) had total debt of 4.41M, with a debt ratio of 0.3. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.
At the end of the period, Pmgc holdings inc. (ELAB) held Total Cash and Cash Equivalents of 7.7M, accounting for 0.52 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, Pmgc holdings inc. (ELAB) did not achieve the “three margins increasing” benchmark, with a gross margin of 27.3%%, operating margin of -768.99%%, and net margin of -907.3%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess ELAB's profit trajectory and future growth potential.
According to the past four quarterly reports, Pmgc holdings inc. (ELAB)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -4.91. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
Pmgc holdings inc. (ELAB)'s Free Cash Flow (FCF) for the period is -1.59M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 99.95% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.